Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 802 results for "herceptin"

Pfizer's Herceptin biosim posts 'encouraging' phase 3 data in blockbuster sales battle
FiercePharma

Pfizer's Herceptin biosimilar candidate successful in late-sta...

A Phase 3 clinical trial, REFLECTIONS B3271002 , comparing the safety and efficacy of Pfizer's (NYSE: PFE ) biosimilar PF-05280014 to Roche's ( OTCQX:RHHBY ) Herceptin (trastuzumab) met the primary endpoint of showing equivalence as measured by ... Seeking Alpha, 5 days ago
[x]  

50 images for herceptin

Cancer Therapy Advisor, 3 days ago
FiercePharma, 5 days ago
Zacks.com, 4 days ago
Libya News Today, 4 days ago
Nasdaq, 4 days ago
Pharmaceutical Tech.com, 4 days ago
Reuters, 5 days ago
Yahoo! India, 5 days ago
srnnews.com, 5 days ago
Nasdaq, 5 days ago
HealthMediciNet.com

Cardiovascular Medications With Chemotherapy Reduce Heart Damage In Cancer Patients

Highlights: Certain medicines like Herceptin for breast cancer treatment may increase the risk of heart damage. Researchers find the combination of heart medications along with chemotherapy to prevent cardiovascular damage during breast cancer ...
 MedIndia5 days ago Study shows heart medications prevent cardiovascular damage during breast cancer treatment  News-Medical.Net6 days ago Drugs prevent heart damage during breast cancer treatment, study show  EurekAlert!6 days ago 'It would save a lot of lives': Rare cancer patients push for better medication access  ABC Online1 month ago
[x]  

Celltrion's Herceptin Biosimilar Submitted For Approval in Europe

According to The Korea Herald, the South Korean biopharma company Celltrion submitted their Herceptin biosimilar, Herzuma, to the European Medicine Agency for approval. Herzuma, a biosimilar to Roche's breast cancer drug Herceptin (trastuzumab), was ...
 JD Supra1 month ago Celltrion seeks EMA approval of Herceptin biosimilar  Korea Herald1 month ago [Photo News] Sharing  Korea Herald1 month ago Samsung Bioepis seeks Europe approval for copy of Herceptin breast cancer drug  Reuters2 months ago

Mylan and Biocon Partnership Updates

, Mylan and Biocon submitted an aBLA for MYL-1401O, a proposed biosimilar to Genentech's Herceptin® (trastuzumab). According to the Mylan press release, this submission is Mylan's first for a biosimilar in the United States, and may lead to the ...
 JD Supra3 weeks ago Mylan submits U.S. marketing application for Herceptin biosimilar  Seeking Alpha3 weeks ago Mylan, Biocon submit application for trastuzumab biosimilar  Pharmacist.com3 weeks ago

Delayed Trastuzumb (Herceptin)-Related ARDS

Extract SESSION TITLE: Student/Resident Case Report Poster - Diffuse Lung Disease SESSION TYPE: Student/Resident Case Report Poster PRESENTED ON: Tuesday, October 25, 2016 at 01:30 PM - 02:30 PM INTRODUCTION: Antineoplastic ...
 CHEST1 month ago
Zacks.com

Pfizer's Herceptin Biosimilar Meets Primary Endpoint in Study

Pfizer, Inc. PFE recently announced that its experimental biosimilar of Roche Holding AG's RHHBY breast cancer drug Herceptin has reached the primary endpoint in a pivotal study. Pfizer shares rose 1.4% in November, comparing favorably with a ...
 Zacks.com4 days ago
[x]  

Success for Pfizer's Trastuzumab Biosimilar in Phase 3 Clinical Trials

Today, Pfizer reported that their trastuzumab biosimilar to Roche's Herceptin® has shown equivalence in a Phase 3 clinical trial measuring objective response rate (ORR) when taken in combination with paclitaxel to treat HER-positive metastatic ...
 JD Supra5 days ago Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight - Research and Markets  Digital Journal1 month ago Global Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight 2016: One of Roche's Three Her2+ Breast Cancer..  ADVFN India1 month ago WORLD ONCOLOGY CONSULT MARKET WORTH USD 111.9 BILLION BY 2020 - ANALYSIS, TECHNOLOGIES & FORECASTS REPORT 2014-2022 - VENDORS : Roche Diagnostics, Novartis, Merck - Research and Markets  4 Traders2 weeks ago
[x]  
Nasdaq

Roche Holding AG 3Q 2016 -- Forecast

=== Sales: -MabTh. 3rd Quarter -Total -Pharma /Rituxan -Avastin -Herceptin AVERAGE 12,553 9,816 1,844 1,786 1,691 Prev. Year 11,940 9,340 1,772 1,705 ...
 Morningstar.com1 month ago Roche Sales Lifted by Cancer Drugs -- Update  ADVFN UK1 month ago Roche Sales Lifted by Cancer Drugs  Nasdaq1 month ago

Forum Post: Preparation for Chemo and herceptin

Hi. Having today had what I consider to be good news in that I had clear margins from my WLE 2 weeks ago and that only 2 out of the 19 nodes removed were cancerous I now have the prospect of chemo and herceptin later to be followed by tamoxifen. I ...
 Macmillan Cancer Support3 days ago Forum Post: RE: Constantly worrying  Macmillan Cancer Support2 hours ago Forum Post: RE: Good news at last...  Macmillan Cancer Support1 week ago Forum Post: Good news at last...  Macmillan Cancer Support1 week ago

Forum Post: RE: Preparation for Chemo and herceptin

Hi Lisea I started my post op treatment in 10th November - I saw the oncologist on the 25th October , had a Muga scan on the 2nd November (not sure if you will have had your heart scan yet - you need this before they will consider giving you ...
 Macmillan Cancer Support3 days ago Forum Post: How long will I feel so Unwell?  Macmillan Cancer Support4 weeks ago Forum Post: RE: Last chemo tomorrow  Macmillan Cancer Support2 weeks ago Forum Post: Last chemo tomorrow  Macmillan Cancer Support2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less